| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $427.5M | +40.0% |
| Cost of Revenue | $129.4M | +16.5% |
| Gross Profit | $298.2M | +53.4% |
| R&D Expense | $72.0M | +57.5% |
| SG&A Expense | $150.8M | +49.2% |
| Operating Income | -$13.1M | +43.7% |
| Pre-tax Income | -$21.1M | +59.8% |
| Income Tax | -$116K | +66.2% |
| Net Income | -$21.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.0M | +23.2% |
| Short-term Investments | $66.3M | +18.4% |
| Accounts Receivable | $74.4M | +98.7% |
| Inventory | $14.0M | +31.0% |
| Current Assets | $268.3M | +35.5% |
| Total Assets | $523.7M | +24.9% |
| Current Liabilities | $108.9M | +98.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.3M | +216.8% |
| Capital Expenditures | $19.0M | +246.3% |
| Investing Cash Flow | -$61.5M | -104.2% |
| Financing Cash Flow | $48.0M | +8.7% |
| Free Cash Flow | $14.3M | +142.0% |
| +59.8% |
| EPS (Basic) | -$0.73 | +62.4% |
| EPS (Diluted) | -$0.73 | +62.4% |
| Long-term Debt |
| $54.5M |
| -2.2% |
| Total Liabilities | $215.5M | +23.8% |
| Stockholders' Equity | $308.2M | +25.7% |